<DOC>
	<DOCNO>NCT00823641</DOCNO>
	<brief_summary>An open-label , non-randomised , uncontrolled , proof-of-concept study eight patient 'definite ' HTLV-I-associated myelopathy/Tropical Spastic Paraparesis ( HAM/TSP ) . Eligible patient either early disease ( less 2 year duration ) progressive disease ( observed clinical deterioration precede 3 month . Following 2 baseline assessment include Magnetic Resonance Imaging ( MRI ) spinal cord lumbar puncture examination fluid around brain ( CSF ) participant treat total 7 infusion anti-TNF-alpha antibody infliximab period 48 week . After last therapy assessment 48 week participant follow 24 week . Study assessments clinical , virological , immunological radiological . MRIs spinal cord obtain week 12 72 . CSF examine , therapy , week 12 .</brief_summary>
	<brief_title>The HAM Infliximab Study</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<mesh_term>Paraparesis , Tropical Spastic</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Are able give inform consent Are 16 year old Have 'definite ' HAM/TSP accord criterion `` Definite HAM/TSP '' agree Belem 200361 Have early progressing disease define : `` Early HAM/TSP '' : Patients must motor disability ( minimum stiffness weakness ) less 2 year . ( Bladder symptoms original presenting symptom assess history include ) `` Progressing HAM/TSP '' New worsen motor symptom patient definite HAM &gt; 2 year duration within last 3 month Hepatitis B hepatitis C infection HIV infection Overt sepsis , abscesses opportunistic infection Active TB ( untreated treatment ) Strongyloides stercoralis ( untreated ) Known hypersensitivity inflixmab , murine protein excipients Malignancy Moderate severe heart failure ( NYHA class III/IV ) Pregnancy breastfeed Unhealed surgical wound Planned impend surgery treatment would withhold 24 week prior major surgery started/restarted postoperatively evidence infection wound heal satisfactory Current immunosuppressive immunomodulatory therapy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HAM/TSP</keyword>
	<keyword>HTLV-I</keyword>
</DOC>